chris beyrer. chris: that was a perfect segue, maureen. because of fierce persistence of new infections, really the problem of h.i.v. incidents, is exactly what the prevention science part of the conference is trying to address. and i think we all have understood that there was a tremendous effort on the part of just countless providers, clinicians, pepfar, national governments to ensure that in the covid pandemic there were not treatment interruptions. everybody understood the centrality of trying to keep people on treatment. but many, many health care that you would put in the category of elective, like, for example, do i need an h.i.v. test today? is it worth going to the clinic and risking exposure to covid? or should i refill that prescription? these really, i think, were more profoundly effective than the treatment area. so we're going to be analyzing for a very long time the impact of covid-19 on that aspect of the h.i.v. pandemic. but we should be clear based on the 2019 data, and everybody will remember that 2020 was supposed to b